Allison Tatman, | |
5423 Killens Pond Rd, Felton, DE 19943-1901 | |
(302) 284-3020 | |
Not Available |
Full Name | Allison Tatman |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 5423 Killens Pond Rd, Felton, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710484605 | NPI | - | NPPES |
L1-0041525 | Other | DE | STATE OF DELAWARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | L1-0041525 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Allison Tatman, 5423 Killens Pond Rd, Felton, DE 19943-1901 Ph: (302) 284-3020 | Allison Tatman, 5423 Killens Pond Rd, Felton, DE 19943-1901 Ph: (302) 284-3020 |
News Archive
However, this precision only concerns the first "door" for the odors' recognition, namely the nose. But something changes when the information collected and processed by the nose arrives in a more central structure of the brain, called the olfactory cortex.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
The American College of Physicians today praised this morning's decision by the U.S. Court of Appeals for the District of Columbia upholding a lower court ruling halting the proposed $54 billion insurance merger between Anthem and Cigna.
TGen Drug Development (TD2) and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.
Discovery Laboratories, Inc. today released new data showing that use of AFECTAIR resulted in as much as a 70 percent reduction in the amount of nitric oxide required to deliver the desired dose of the therapeutic gas when compared with current standard of care.
› Verified 5 days ago
Virginia Marie Serrano, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 545 Indian Point Rd, Felton, DE 19943 Phone: 302-359-8503 | |
Jean Callaway, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5423 Killens Pond Rd, Felton, DE 19943 Phone: 302-284-3020 | |
Christina Roberts, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5423 Killens Pond Rd, Felton, DE 19943 Phone: 302-284-5810 | |
John Rocks, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 172 Charlies Ct, Felton, DE 19943 Phone: 302-222-8626 | |
Jessica K. Everett, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 55 Hackberry Drive, Felton, DE 19943 Phone: 302-222-4577 | |
Nataleen Villabona, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3227 Little Mastens Corner Rd, Felton, DE 19943 Phone: 302-382-3004 |